Top drug regulator Richard Pazdur filed papers to retire from the Food and Drug Administration at the end of this month, according to two agency sources familiar with the matter, STAT News’ Lizzy Lawrence reports. Pazdur informed leaders at the FDA’s drug center of his intention to leave the agency at a meeting on Tuesday. He could still retract the papers, the author notes. The move comes less than a month after he took the role at the urging of FDA Commissioner Marty Makary.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Vaccine committee considers changes to childhood schedule, NY Times reports
- Johnson & Johnson price target raised to $197 from $176 at Barclays
- Midday Fly By: Nvidia invests in Synopsys, U.S. strikes pharma deal with UK
- Trump Trade: U.S. confirms agreement with U.K. on pharmaceutical pricing
- Is AstraZeneca’s Stock (AZN) a Good Investment Right Now?